Table 5. | Characteristics of included study |
| Study |
Number of patients |
Age (years) |
Group of study | Bone graft | PRF type | |
|---|---|---|---|---|---|---|
| Test group | Control group | |||||
| Nizam et al. [17] | 13 | 49.92 (SD 10.37) |
MSFA DBBM + L-PRF (n = 13) |
MSFA DBBM alone (n = 13) |
DBBM | L-PRF |
| Pichotano et al. [18] | 12 | 54.17 (SD 6.95) |
MSFA DBBM + L-PRF (n = 13) |
MSFA DBBM alone (n = 13) |
DBBM | L-PRF |
| Salimzade et al. [19] |
15 (30 MSFA) |
53.6 (SD 0.18) |
MSFA PRF with bone graft (n = 15) |
MSFA bone graft with membrane (n = 15) |
DBBM | L-PRF |
| de Almeida Malzoni et al. [20] | 24 | 54.08 (SD 10.07) |
MSFA L-PRF with bone graft (n = 24) |
MSFA only bone graft (n = 12) |
DBBM | L-PRF |
| Shiezadeh et al. [21] | 20 |
Group with PRF: 42.7 (SD 5.79); Group without PRF: 40.3 (SD 4.83) |
MSFA PRF with bone graft (n = 10) |
MSFA-only bone graft (n = 10) |
Allograft | PRF |
MSFA = maxillary sinus floor augmentation; DBBM = deproteinized bovine bone mineral; PRF = platelet rich fibrin; L-PRF = leukocytes platelet rich fibrin; n = number of maxillary sinus floor augmentation procedures; SD = standard deviation. |
.png)
.png)
.png)
.png)
.png)